Abstract
Parkinson's disease is an idiopathic, relentlessly progressive, neurologic disorder manifested clinically by tremor, bradykinesia, rigidity, and postural instability. After completing the diagnostic procedure and having verified the need to start drug treatment, we follow the criteria for therapy aimed at maximum benefits with minimal side effects in the short and long term. This paper examines, step by step, the different treatment options.
| Original language | English |
|---|---|
| Pages (from-to) | 117-122 |
| Number of pages | 6 |
| Journal | Acta Medica Mediterranea |
| Volume | 28 |
| Issue number | 2 |
| Publication status | Published - 2012 |
Fingerprint
Keywords
- Dopamine agonist therapy
- L-dopa
- Parkinson's disease
- Parkinsonism
ASJC Scopus subject areas
- Medicine(all)
Cite this
Parkinson's disease : Therapeutic options. / Rampello, Luigi; Vecchio, Ignazio; Malaguarnera, Michele; Battaglia, Giuseppe; Rampello, Liborio.
In: Acta Medica Mediterranea, Vol. 28, No. 2, 2012, p. 117-122.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Parkinson's disease
T2 - Therapeutic options
AU - Rampello, Luigi
AU - Vecchio, Ignazio
AU - Malaguarnera, Michele
AU - Battaglia, Giuseppe
AU - Rampello, Liborio
PY - 2012
Y1 - 2012
N2 - Parkinson's disease is an idiopathic, relentlessly progressive, neurologic disorder manifested clinically by tremor, bradykinesia, rigidity, and postural instability. After completing the diagnostic procedure and having verified the need to start drug treatment, we follow the criteria for therapy aimed at maximum benefits with minimal side effects in the short and long term. This paper examines, step by step, the different treatment options.
AB - Parkinson's disease is an idiopathic, relentlessly progressive, neurologic disorder manifested clinically by tremor, bradykinesia, rigidity, and postural instability. After completing the diagnostic procedure and having verified the need to start drug treatment, we follow the criteria for therapy aimed at maximum benefits with minimal side effects in the short and long term. This paper examines, step by step, the different treatment options.
KW - Dopamine agonist therapy
KW - L-dopa
KW - Parkinson's disease
KW - Parkinsonism
UR - http://www.scopus.com/inward/record.url?scp=84870831093&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84870831093&partnerID=8YFLogxK
M3 - Article
VL - 28
SP - 117
EP - 122
JO - Acta Medica Mediterranea
JF - Acta Medica Mediterranea
SN - 0393-6384
IS - 2
ER -